Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 122

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME): An Extension of the STROBE Statement

Gallo, Valentina, Egger, Matthias, McCormack, Valerie, Farmer, Peter B., Ioannidis, John P. A., Kirsch-Volders, Micheline, Matullo, Giuseppe, Phillips, David H., Schoket, Bernadette, Stromberg, Ulf, Vermeulen, Roel, Wild, Christopher, Porta, Miquel, Vineis, Paolo·2011·PLoS Medicine
DOI 10.1371/journal.pmed.1001117
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1001117

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 37

  1. P Vineis, 2004, Individual susceptibility to carcinogens., Oncogene, 23, 6477, 10.1038/sj.onc.1207897 · DOI
  2. S Bonassi, 2002, Biomarkers in molecular epidemiology studies for health risk prediction., Mutat Res, 511, 73, 10.1016/S1383-5742(02)00003-0 · DOI
  3. R Milikan, 2002, The changing face of epidemiology in the genomics era., Epidemiology, 13, 472, 10.1097/00001648-200207000-00017 · DOI
  4. DJ Hunter, 1999, The future of molecular epidemiology., Int J Epidemiol, 28, S1012, 10.1093/oxfordjournals.ije.a019903 · DOI
  5. AG Rundle, 2005, Design options for molecular epidemiology research within cohort studies., Cancer Epidemiol Biomarkers Prev, 14, 1899, 10.1158/1055-9965.EPI-04-0860 · DOI
  6. PA Kyzas, 2007, Almost all articles on cancer prognostic markers report statistically significant results., Eur J Cancer, 43, 2559, 10.1016/j.ejca.2007.08.030 · DOI
  7. A Blair, Epidemiology, public health and the rhetoric of false positives., Environ Health Perspect, 2009;117, 1809
  8. PA Kyzas, 2005, Selective reporting biases in cancer prognostic factor studies., J Natl Cancer Inst, 14, 1043, 10.1093/jnci/dji184 · DOI
  9. JPA Ioannidis, 2011, Comparison of effect sizes of biomarkers reported in highly-cited articles versus subsequent meta-analyses., JAMA, 305, 2200, 10.1001/jama.2011.713 · DOI · Paper page
  10. AE Fung, 2009, Applying the CONSORT and STROBE statements to evaluate the reporting quality of neovascular age-related macular degeneration studies., Ophthalmology, 116, 286, 10.1016/j.ophtha.2008.09.014 · DOI
  11. B Da Costa, 2010, Uses and misuses of the STROBE statement: bibliographic study., BMJ Open, bmjopen-2010-000048
  12. J Little, 2009, Strengthening the reporting of genetic association studies (STREGA)-an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement., J Clin Epidemiol, 62, 597, 10.1016/j.jclinepi.2008.12.004 · DOI
  13. DA Haines, 2011, Reporting results of human biomonitoring of environmental chemicals to study participants: a comparison of approaches followed in two Canadian studies., J Epidemiol Community Health, 65, 191, 10.1136/jech.2008.085597 · DOI
  14. DF Ransohoff, 2004, Rules of evidence for cancer molecular-marker discovery and validation., Nat Rev Cancer, 4, 309, 10.1038/nrc1322 · DOI · Paper page
  15. M Porta, 2009, Influence of tumor stage, symptoms and time of blood draw on serum concentrations of organochlorine compounds in exocrine pancreatic cancer., Cancer Causes Control, 20, 1893, 10.1007/s10552-009-9383-2 · DOI
  16. M Porta, 2007, Timing of blood extraction in epidemiologic and proteomic studies. Results and proposals from the PANKRAS II Study., Eur J Epidemiol, 22, 577, 10.1007/s10654-007-9149-7 · DOI
  17. M Ruchirawa, 2002, Exposure to genotoxins present in ambient air in Bangkok, Thailand – particle associated polycyclic aromatic hydrocarbons and biomarkers., Sci Total Environ, 287, 121, 10.1016/S0048-9697(01)01008-7 · DOI
  18. M Sorensen, 2003, Personal exposure to PM2.5 and biomarkers of DNA damage., Cancer Epidemiol Biomarkers Prev, 12, 191
  19. M Dusinska, 2002, DNA damage and antioxidants; fluctuations through the year in a central European population group., Food Chem Toxicol, 40, 1119, 10.1016/S0278-6915(02)00055-8 · DOI
  20. L Giovannelli, 2002, Nutritional and lifestyle determinants of DNA oxidative damage: a study in a Mediterranean population., Carcinogenesis, 23, 1483, 10.1093/carcin/23.9.1483 · DOI
  21. P Moller, 2002, Sunlight-induced DNA damage in human mononuclear cells., FASEB J, 16, 45, 10.1096/fj.01-0386com · DOI
  22. JPA Ioannidis, 2007, Genetic and molecular epidemiology., J Epidemiol Community Health, 61, 757, 10.1136/jech.2006.059055 · DOI
  23. DH Phillips, 1999, Standardization and validation of DNA adduct postlabelling methods: report of interlaboratory trials and production of recommended protocols., Mutagenesis, 14, 301, 10.1093/mutage/14.3.301 · DOI
  24. PJ Castaldi, 2011, An empirical assessment of validation practices for molecular classifiers., Brief Bioinform, 12, 189, 10.1093/bib/bbq073 · DOI
  25. DG Altman, 2000, What do we mean by validating a prognostic model?, Stat Med, 4, 453, 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5 · DOI
  26. NE Caporaso, 2002, Why have we failed to find the low penetrance genetic constituents of common cancers?, Cancer Epidemiol Biomarkers Prev, 11, 1544
  27. H Vainio, 2004, Genetic biomarkers and occupational epidemiology – recollections, reflections and reconsiderations., Scand J Work Environ Health, 30, 1, 10.5271/sjweh.759 · DOI
  28. D Moher, 2010, Guidance for developers of health research reporting guidelines., PLoS Med, 7, e1000217, 10.1371/journal.pmed.1000217 · DOI · Paper page
  29. P Vineis, 2007, Molecular epidemiology and biomarkers in etiologic cancer research: the new in light of the old., Cancer Epidemiol Biomarkers Prev, 16, 1954, 10.1158/1055-9965.EPI-07-0457 · DOI
  30. AJ Atkinson, 2001, Biomarkers and surrogate endpoints: preferred definitions and conceptual framework., Clin Pharmacol Ther, 69, 89, 10.1067/mcp.2001.113989 · DOI · Paper page
  31. I Decordier, 2010, Phenotyping for DNA repair capacity., Mutat Res, 705, 107, 10.1016/j.mrrev.2010.05.002 · DOI
  32. RD Riley, 2009, Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond., Br J Cancer, 100, 1219, 10.1038/sj.bjc.6604999 · DOI
  33. DE Sigounas, 2011, New prognostic markers for outcome of acute pancreatitis: overview of reporting in 184 studies., Pancreas, 40, 522, 10.1097/MPA.0b013e31820bf8ac · DOI
  34. V Gallo, 2008, Validation of biomarkers for the study of environmental carcinogens: a review., Biomarkers, 13, 505, 10.1080/13547500802054611 · DOI
  35. P Kristensen, 1992, Bias from nondifferential but dependent misclassification of exposure and outcome., Epidemiology, 3, 210, 10.1097/00001648-199205000-00005 · DOI
  36. P Vineis, 1997, Sources of variation in biomarkers., IARC Sci Publ, 142, 59
  37. K Vahakangas, 2004, Ethical aspects of molecular epidemiology of cancer., Carcinogenesis, 25, 465, 10.1093/carcin/bgh043 · DOI

Cited by

See all 122

Metadata

Authors
Gallo, V., Egger, M., McCormack, V., Farmer, P. B., Ioannidis, J. P. A., Kirsch-Volders, M., Matullo, G., Phillips, D. H., Schoket, B., Stromberg, U., Vermeulen, R., Wild, C., Porta, M., & Vineis, P.
Venue
PLoS Medicine
Publisher
Public Library of Science (PLoS)
Published
2011-10-25
Volume
8
Issue
10
Pages
e1001117
ISSN
1549-1676
DOI
10.1371/journal.pmed.1001117
Cited by
122
References
11
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.